NIAID Advanced Technology SBIR (NIAID-at-SBIR [R43/R44])
The summary for the NIAID Advanced Technology SBIR (NIAID-at-SBIR [R43/R44]) Federal Grant is detailed below.
It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section.
If these sections are incomplete, please visit the website of the government agency that is offering this grant.
| Federal Grant Title: | NIAID ADVANCED TECHNOLOGY SBIR (NIAID-AT-SBIR [R43/R44]) |
| Federal Agency Name: | National Institutes of Health |
| Program Name: | Allergy, Immunology and Transplantation Research |
| Grant Categories: | Health |
| CFDA Number: | 93.855 |
| Funding Opportunity Number: | PA-09-115 |
| Posted Date: | Feb 27, 2009 |
| Creation Date: | Feb 27, 2009 |
| Original Application Deadline: | Jan 07, 2010 |
| Current Application Deadline: | Jan 07, 2010 |
| Archive Date: | Feb 07, 2010 |
| Total Program Funding: | Information not provided |
| Maximum Federal Grant Award: | Information not provided |
| Minimum Federal Grant Award: | Information not provided |
| Expected Number of Awards: | Information not provided |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Information not provided
- Grant Description
- Purpose. This funding opportunity announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for advanced technology projects that require a longer award period and greater award amount than those routinely allowed under the SBIR program. For this FOA, "advanced technology" is defined as a clearly identified product or service that requires approval of the Food and Drug Administration (FDA) and is in one of the following three research areas: A vaccine, biologic, or drug to treat an infectious disease, an immunologic disease, allergy, or transplantation; A vaccine, biologic or drug delivery system; Assays for the diagnosis of an infectious disease, immunologic disease, allergic disease, or as an aid to transplantation, or therapeutic monitoring systems for clinical trials of vaccines, biologics, drugs or transplantation. An example of a clearly identified product is a research project focused on a lead compound for an AIDS drug. A research project focused on developing an assay to identify lead compounds does not have a clearly identified product and would not be appropriate for this FOA. Only applications meeting the above advanced technology definition should be submitted in response to this FOA. Applications in response to this FOA should not contain human clinical trials.
- Link to Full Grant Announcement
-
http://grants.nih.gov/grants/guide/pa-files/pa-09-115.html
- Grant Announcement Contact
- NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV] - Similar Government Grants
- • Pharmacological Approaches to Evaluating Drug Regimens to Address Antimicrobial Resistance...
- • Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)
- • Drug Target Development and Validation for Antimicrobial-Resistant Pathogens (R21/R33)
- • NIAID Clinical Trial Implementation Cooperative Agreement (U01)
- • NIAID Clinical Trial Implementation Grant (R01)
- • Center for HIV/AIDS Vaccine Immunology (CHAVI)
- • Genomics of Transplantation Cooperative Research Program
- • Asthma and Allergic Diseases Cooperative Research Centers
- More Grants from the National Institutes of Health
- • NIAMS Clinical Trial Outcome Instrument Development Grant Program (U01)
- • Biophysical and Biomechanical Aspects of Embryonic Development (R01)
- • Biophysical and Biomechanical Aspects of Embryonic Development (R21)
- • Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agricultural...
- • MARC Undergraduate Student Training in Academic Research (U-STAR) National Research Servic...